The V domain of dog PVRL4 (nectin-4) mediates canine distemper virus entry and virus cell-to-cell spread  by Delpeut, Sebastien et al.
The V domain of dog PVRL4 (nectin-4) mediates canine distemper
virus entry and virus cell-to-cell spread
Sebastien Delpeut a,b,1, Ryan S. Noyce a,b,1, Christopher D. Richardson a,b,c,n
a The Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada B3H 1X5
b IWK Health Centre, Canadian Center for Vaccinology, Goldbloom Pavilion, Halifax, Nova Scotia, Canada B3H 1X5
c The Department of Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada
a r t i c l e i n f o
Article history:
Received 21 December 2013
Returned to author for revisions
25 January 2014
Accepted 11 February 2014













a b s t r a c t
The entry of canine distemper virus (CDV) is a multistep process that involves the attachment of CDV
hemagglutinin (H) to its cellular receptor, followed by fusion between virus and cell membranes. Our
laboratory recently identiﬁed PVRL4 (nectin-4) to be the epithelial receptor for measles and canine
distemper viruses. In this study, we demonstrate that the V domain of PVRL4 is critical for CDV entry and
virus cell-to-cell spread. Furthermore, four key amino acid residues within the V domain of dog PVRL4
and two within the CDV hemagglutinin were shown to be essential for receptor-mediated virus entry.
& 2014 Elsevier Inc. All rights reserved.
Introduction
In the order Mononegavirales, measles virus (MeV) and canine
distemper virus (CDV) belong to the genus Morbillivirus in the
family Paramyxoviridae (Diallo, 1990; Rima and Duprex, 2006).
Although MeV mainly causes a moderate disease in humans and
certain non-human primates (de Vries et al., 2010), MeV-induced
suppression of the immune system can result in an increased
susceptibility to lethal secondary infections (Avota et al., 2010;
Beckford et al., 1985). On the other hand, distemper viruses affect a
wide range of canine and marine mammals causing mild discom-
fort to serious, neurological disease (Appel, 1970; Barrett, 1999;
Deem et al., 2000; Harder and Osterhaus, 1997; Martella et al.,
2008). Interestingly, CDV infections also occur in wild and captive
feline populations (Daoust et al., 2009; Furtado et al., 2013; Nagao
et al., 2012; Nava et al., 2008; Quigley et al., 2010; Terio and Craft,
2013).
Morbilliviruses infect a broad range of immune and epithelial
cells (Sato et al., 2012). Speciﬁc interactions between cellular
receptors and the viral hemagglutinin protein (H) facilitate virus
entry and spread in host cells (Sato et al., 2012) by inducing virus–
cell and cell–cell membrane fusion in cooperation with the fusion
protein (F) (Baker et al., 1999; Colman and Lawrence, 2003;
Hernandez et al., 1996; Takimoto et al., 2002). To date, two cellular
receptors have been identiﬁed for CDV: (i) the morbillivirus
receptor SLAM (signaling lymphocyte activation molecule), which
is expressed on the surface of activated T- and B-lymphocytes,
macrophages, and dendritic cells (Cocks et al., 1995; Hsu et al.,
2001; Sidorenko and Clark, 1993; Tatsuo et al., 2000, 2001; von
Messling et al., 2004, 2005) and (ii) PVRL4 (poliovirus-receptor-
like-4; also known as nectin-4), the most recently identiﬁed
receptor for morbilliviruses, which is found on epithelial cells
(Birch et al., 2013; Muhlebach et al., 2011; Noyce et al., 2011; Noyce
et al., 2013; Noyce and Richardson, 2012; Pratakpiriya et al., 2012).
Interestingly, CDV has the intrinsic ability to use both human and
dog PVRL4, without requiring adaptive mutations in H (Bieringer
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et al., 2013; Noyce et al., 2013; Sakai et al., 2013). CDV can also
readily adapt to use the human SLAM receptor through a single
mutation in its hemagglutinin gene (Bieringer et al., 2013; Sakai
et al., 2013), suggesting that CDV has the potential to emerge as a
novel human pathogen (Sakai et al., 2013).
PVRL4 is a member of the nectin family of adhesion molecules
that belong to the immunoglobulin (Ig) superfamily, comprised of
nectin-1, -2, -3 and -4, as well as the prototypic poliovirus receptor
(PVR) (Kurita et al., 2011; Takai et al., 2008a, 2008b). Nectins are
normally localized to the adherens junctions, and are components
of the cell–cell adhesion system where they play a key role in
limiting cell movement, facilitating intercellular communication,
and regulating proliferation (Kurita et al., 2011; Takai et al., 2008a,
2008b). PVRL4 is a type I transmembrane glycoprotein with three
Ig-like ectodomains (V, and two C2 domains), a transmembrane
region, and a cytoplasmic tail (Fabre et al., 2002; Takai et al.,
2008b). V domains are involved in homotypic and heterotypic
interactions between the nectins, while C2 domains enhance the
afﬁnity of these interactions (Fabre et al., 2002; Satoh-Horikawa
et al., 2000; Takai et al., 2008a).
Given that the V domain of human PVRL4 was previously shown to
bind strongly to MeV and facilitate virus attachment and entry into
cells (Muhlebach et al., 2011) and that the 3-D structure of V
complexed to the H protein of MeV was reported (Zhang et al.,
2013), we sought to functionally characterize key amino acid residues
within the V domain of dog PVRL4 that are important for CDV entry.
Molecular studies evaluating the interactions of the V domain during
infection or membrane fusion experiments have not be been pre-
viously reported. We took advantage of the fact that Vero cells are not
susceptible to CDV infection due to the absence of PVRL4 expression.
However, there are low amounts of PVRL1 in Vero cells that cannot
function as a receptor (Muhlebach et al., 2011; Noyce et al., 2011).
Chimeric molecules were engineered in one polypeptide where the V
domain of dog PVRL4 was replaced with the V domain of human
PVRL1, and in another polypeptide where the V domain of human
PVRL1 was replaced with the V domain of dog PVRL4. Key residues
within the V domain of dog PVRL4 and the CDV hemagglutinin that
dictate receptor-mediated virus entry were identiﬁed by mutational
analysis.
Results
Chimeric dog PVRL4 and PVRL1 protein receptors localize to the cell
surface
Based upon the alignment of dog and human nectin sequences in
the V domain showing low sequence homology (Fig. 1A), chimeric dog
PVRL4 and human PVRL1 molecules were created by replacing the V
domain of dog PVRL4 with the V domain from human PVRL1 (dog.
PVRL4/VhPVRL1) and the V domain of human PVRL1 with the V domain
of dog PVRL4 (hPVRL1/Vdog.PVRL4) (Fig. 1B). Chimeric molecules were
expressed in Vero cells. Flow cytometry analysis revealed that dog.
PVRL4, dog.PVRL4/VhPVRL1 and hPVRL1/Vdog.PVRL4 proteins localized to
the plasma membrane, although the PVRL4 staining was absent in the
dog.PVRL4/VhPVRL1 cells, since the antibodies only recognize the V
domain peptide (Fig. 2). Vero and Vero.dog.PVRL4 cell lines expressed
comparable low levels of endogenous PVRL1. However, there were
increased levels of PVRL1 cell surface ﬂuorescence on the Vero.dog.
PVRL4/VhPVRL1 and Vero.hPVRL1/Vdog.PVRL4 expressing cell lines.
Together, these data suggest that the majority of the Vero.dog.
PVRL4/VhPVRL1 and Vero.hPVRL1/Vdog.PVRL4 cells express the chimeric
dog PVRL4 and chimeric human PVRL1 proteins at the cell surface
membrane, respectively. In addition, the V domain of both PVRL1 and
PVRL4 contain important epitopes that are recognized by their
respective antibodies.
The V domain of dog PVRL4 is essential for CDV 5804PeH infection
To address the contribution of the V domain from dog PVRL4 in
CDV entry, the Vero stable cell lines that expressed the chimeric
receptors were infected with CDV 5804PeH (von Messling et al.,
2004) and monitored for syncytia formation and virus production
(Fig. 3). Syncytia formation was observed in the Vero.dog.PVRL4
and Vero.hPVRL1/Vdog.PVRL4 cell lines but not in cells expressing
dog.PVRL4/VhPVRL1 (Fig. 3A). Interestingly, smaller syncytia were
detected in Vero.hPVRL1/Vdog.PVRL4 cells infected with CDV,
suggesting that the V domain may not be solely responsible for
efﬁcient viral infection. At three days post-infection (dpi), CDV
5804PeH titers were higher in the Vero cells expressing dog.PVRL4
and hPVRL1/Vdog.PVRL4 proteins compared to the Vero and the
Vero.dog.PVRL4/VhPVRL1 cell lines (Fig. 3B). We previously
observed low levels of CDV production without syncytia formation
in Vero cells lacking dog nectin-4 (Noyce et al., 2013). These
background infections produced titers 2–3 logs below that of cells
expressing SLAM or PVRL4. We postulate that the virus can enter
these cells by an F protein-independent mechanism such as
macropinocytosis and may or may not be relevant during in vivo
infections. Taken together, the preceding data suggest that the V
Fig. 1. Amino acid sequences of all human PVRL molecules and dog PVRL4 in the V
domain. (A) Sequence alignment of the V domain from human PVRL1 to PVRL4,
human PVR, and dog PVRL4. Residues having similarity are shaded (dark shading
represents identical amino acid residues; dark gray shading represents residues
with 80–100% identity, light gray shading represents residues with 60–80%
identity, no shading represents residues with less than 60% identity). The
consensus FPxG amino acid sequence is boxed in red. Pairwise protein alignments
were performed using Geneious sequence alignment software (Drumond et al.,
2010). (B) Schematic diagrams of the wild-type and chimeric dog PVRL4 and
human PVRL1 proteins (dog.PVRL4, dog.PVRL4/VhPVRL1, hPVRL1 and hPVRL1/Vdog.
PVRL4). The V and C2 domains, along with the transmembrane domain (TM) are
indicated.
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domain of dog PVRL4 plays an important role in both CDV entry
and virus cell-to-cell spread in vitro. Thus, the V domain of dog
PVRL4 is sufﬁcient to convert human PVRL1 into a functional CDV
entry receptor, indicating that the V domain of dog PVRL4 contains
the critical determinants for CDV entry into cells.
The P493/Y539 residues in CDV H are involved in dog PVRL4-
mediated fusion
Before the discovery of PVRL4 as the epithelial cell receptor for
CDV (Noyce et al., 2013; Pratakpiriya et al., 2012), Sawatsky et al.
demonstrated that CDV H bearing the double mutations P493S/
Y539A (CDV HP493S/Y539A) was unable to infect epithelial cells,
while still retaining the ability to infect SLAM positives cells and
form syncytia (Sawatsky et al., 2012). To conﬁrm that these
residues were important for binding to dog PVRL4, plasmids
expressing either CDV H or CDV HP493S/Y539A were co-transfected
into Vero, Vero.dog.PVRL4, Vero.dog.PVRL4/VhPVRL1, Vero.hPVRL1/
Vdog.PVRL4 and Vero.dog.SLAM cells together with a plasmid
expressing CDV F. At different times after transfection, cells were
stained with Giemsa and syncytia formation was assessed (Fig. 4).
No syncytia were detected in control Vero cells expressing CDV F
Fig. 2. Cell surface expression of chimeric PVRL molecules (dog.PVRL4, dog.PVRL4/VhPVRL1 and hPVRL1/Vdog.PVRL4). The ﬂow cytometric histograms depict the cell surface
expression proﬁle of PVRL4 and PVRL1 in the corresponding cell line (isotype ctrl antibody, IgG – shaded; PVRL4 antibody, PVRL4 – blue; PVRL1 antibody, PVRL1 – green).
Vero stable cell lines were incubated with either a phycoerythrin (PE)-conjugated mouse monoclonal antibody speciﬁc for human PVRL4, a PE-conjugated mouse IgG2a
control antibody, an allophycocyanin (APC)-conjugated mouse monoclonal antibody speciﬁc for human PVRL1 or an APC-conjugated mouse IgG2B control antibody.
The Y-axis represents cell counts and the X-axis represents ﬂuorescence intensity (FL8: APC; FL2: PE).
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together with CDV H or CDV HP493S/Y539A (Fig. 4A and B). However,
large syncytia were observed in Vero.dog.SLAM cells expressing
CDV F and either CDV H or HP493S/Y539A (Fig. 4C and D).
Co-expression of both wild-type CDV F and H glycoproteins also
produced syncytia in Vero.dog.PVRL4 (Fig. 4E) and Vero.hPVRL1/
Vdog.PVRL4 cells (Fig. 4I), but not in Vero.dog.PVRL4/VhPVRL1 cells
(Fig. 4G). Strikingly, the Vero.hPVRL1/Vdog.PVRL4 cell line was found
to be less efﬁcient in forming syncytia, as evidenced by a reduction
in the number and size of syncytia (Fig. 4I). Increasing the amount
of both CDV glycoproteins expressed on the cell surface did not
improve the extent of syncytia formation in Vero.hPVRL1/Vdog.PVRL4
cells (data not shown). As anticipated, the co-expression of the
mutated CDV HP493S/Y539A together with CDV F did not induce
syncytia formation in the Vero.dog.PVRL4, Vero.hPVRL1/Vdog.PVRL4
and Vero.dog.PVRL4/VhPVRL1 cell lines (Fig. 4F, H and J). These data
conﬁrm that the dog PVRL4 V domain plays a key role in PVRL4-
dependent cell–cell fusion. As well, the P493/Y539 residues in CDV H
are involved in dog PVRL4-mediated fusion, although it is still unclear
whether these residues are directly involved in binding to dog PVRL4,
or if they facilitate a subsequent step with CDV F during PVRL4-
dependent fusion.
The F132/P133/A134/G135 residues in the V domain of dog PVRL4 are
critical for wild-type CDV strain 5804-receptor function
The putative amino acid residues within human PVRL4 that are
critical for binding to the MeV H protein are located in the V domain
(Zhang et al., 2013). However, the previous structural study showing
interaction of MeV Hwith the V domain of PVRL4 (Zhang et al., 2013)
failed to show the signiﬁcance of this complex during actual
infections by the virus. Interestingly, the V domain of human PVRL4
is highly similar to its dog homolog (Noyce et al., 2013). To determine
whether the residues previously identiﬁed by Zhang et al. could
play a key role in dog PVRL4 function, we introduced compar-
able mutations from human PVRL4 to dog PVRL4 that abolished
receptor interaction with MeV-H and CDV-H. These consisted of the
four mutations F132S/P133S/A134S/G135Y (dog.PVRL4/VFPAG-SSSY)
(Fig. 1A), from which we created a cell line expressing this mutant
PVRL4 (Vero.dog.PVRL4/VFPAG-SSSY). Flow cytometry analysis con-
ﬁrmed that the majority of cells in the stable population expressed
dog.PVRL4/VFPAG-SSSY at the cell surface membrane (Fig. 5A). The
Vero.dog.PVRL4 and Vero.dog.PVRL4/VFPAG-SSSY cell lines were
infected with CDV at an MOI of 0.5, after which syncytia formation
and virus titers were monitored at 3 days post-infection (Fig. 5B). As
expected, syncytia formation was observed in cells expressing dog
PVRL4 but not in the Vero.dog.PVRL4/VFPAG-SSSY cell line (Fig. 5B). At
3 days post-infection, CDV 5804PeH virus titers were signiﬁcantly
higher in the Vero cells expressing dog PVRL4 as compared to the
Vero control cells (Fig. 5C). The CDV 5804PeH virus replicated to yield
lower titers in both Vero.dog.PVRL4/VFPAG-SSSY and Vero cell lines.
Taken together, these results demonstrate that the F132/P133/A134/
G135 residues within the V domain of dog PVRL4 play key roles in
PVRL4-dependent virus production and PVRL4-dependent virus–cell
and cell–cell fusion.
Fig. 3. CDV 5804PeH replication in wild-type, chimeric dog PVRL4 and human PVRL1-expressing Vero stable cell lines. Vero.dog.PVRL4, Vero.dog.PVRL4/VhPVRL1, Vero.
hPVRL1/Vdog.PVRL4, and Vero cells were seeded on twelve-well plate (1105 cells/well) 1 day before infection with CDV 5804PeH at an MOI of 0.5. (A) Fluorescence images
were captured three days post infection and overlaid with phase contrast images to visualize the extent of virus replication (GFP) and syncytia formation. (B) CDV-infected
cells were harvested at 3 days post-infection and titered on Vero.dog.SLAM cells. Data are the means from three independent experiments, and error bars represent the SEM.
Analysis of variance (ANOVA) was performed to identify statistically signiﬁcant differences in CDV 5804PeH titrations. P values below 0.05 were considered statistically
signiﬁcant.
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Discussion
Recently, PVRL4 was identiﬁed as a novel epithelial receptor for
several morbilliviruses, including MeV, CDV and peste des petits
ruminants virus (Birch et al., 2013; Muhlebach et al., 2011; Noyce
et al., 2011, 2013; Pratakpiriya et al., 2012). MeV H recognizes the
V domain of human PVRL4 leading to virus entry into the host cell
(Muhlebach et al., 2011). Notably, both MeV hemagglutinin and
PVRL4 V domain residues involved in MeV H–PVRL4 binding inter-
face have been identiﬁed through X-ray crystallography (Zhang et al.,
2013), although these residues were never validated in viral infectiv-
ity or fusion assays. In this study, we characterized a series of
residues within the CDV hemagglutinin protein and the V domain
of dog PVRL4, which were found to be essential for effective dog
PVRL4-mediated virus production or virus–cell and cell–cell fusion.
Although CDV and MeV H are 36% identical (Haas et al., 1999;
von Messling et al., 2001), both MeV and CDV hemagglutinin are
predicted to fold as a propeller six beta-sheet of four strands
each (von Messling et al., 2005), suggesting they may share
similar receptor-binding surfaces. Recently, the double mutations
Fig. 4. Characterization of CDV glycoproteins-induced cell–cell fusion in wild-type, chimeric dog PVRL4 and human PVRL1-expressing Vero stable cell lines. Vero.dog.PVRL4,
Vero.dog.PVRL4/VhPVRL1, Vero.hPVRL1/Vdog.PVRL4, Vero.dog.SLAM, and Vero cells were cotransfected with plasmid encoding CDV F together with CDV H or CDV HP493S/Y539A.
At 48 h post transfection, cells were stained with Giemsa as described in Materials and methods. Light microscopy images were captured to visualize the extent of syncytia
formation. Arrow heads indicate the location of representative syncytia in transfected cells.
S. Delpeut et al. / Virology 454-455 (2014) 109–117 113
P493S/Y539A in CDV H, which correspond to P497S and Y543A
mutations conferring the PVRL4-blind phenotype in MeV H
(Leonard et al., 2008), were shown to abolish CDV infection in
epithelial cells (Sawatsky et al., 2012). Consistent with this report,
we demonstrated that the P493/Y539 residues in CDV H are
involved in dog PVRL4-mediated fusion, indicating that morbilli-
virus H protein residues important for epithelial cell infection are
conserved. Interestingly, Mateo et al. demonstrated a wide
functional overlap between the CD46 and PVRL4 interaction sites
within the H protein β4–β5 hydrophobic groove fromMeV vaccine
strains, while the SLAM binding site is separated (Mateo et al.,
2013). On the other hand, non-overlapping SLAM and PVRL4-
binding sites on H protein likely explain why PVRL4-blind CDV
retains its ability to fuse cells expressing SLAM.
Here we exchanged the V domains of human PVRL1 and dog
PVRL4 and examined their roles in CDV infectivity. The human
Fig. 5. Mutation of the CDV-H binding pocket on dog PVRL4 prevents efﬁcient wtCDV entry and syncytia formation. (A) Flow cytometry analysis reveals PVRL4 surface
expression in chimeric Vero.dog.PVRL4/VFPAG-SSSY stable cell line. Vero stable cell lines were incubated with a PE-conjugated antibody speciﬁc for human PVRL4 (red
histograms), or a PE-conjugated isotype control antibody (shaded histograms). (B) Phase contrast and ﬂuorescence images were captured and overlaid to visualize the extent
of virus replication (GFP) and syncytia formation over 3d. (C) Mutation of the putative CDV-H binding pocket on dog PVRL4 results in a signiﬁcant decrease in CDV 5804PeH
virus titers compared to dog PVRL4 cells. CDV-infected cells were harvested 3 days post infection and titered on Vero.dog.SLAM cells. Data are means from three independent
experiments, and error bars represent SEM. Analysis of variance (ANOVA) was performed to identify statistically signiﬁcant differences in CDV 5804PeH titrations. P values
below 0.05 were considered statistically signiﬁcant.
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chimeric PVRL1 molecule containing the V domain of dog PVRL4
yielded similar CDV titers when compared to wild type dog PVRL4,
whereas the dog PVRL4 chimera containing the V domain of
human PVRL1 failed to support productive CDV replication. Thus,
we have demonstrated for the ﬁrst time that dog PVRL4 V domain
contains critical determinants for CDV infection using chimeric
nectin molecules expressed at the cell surface membrane. Surpris-
ingly, both CDV infection and virus-free syncytia assays revealed
that syncytia formation was reduced in Vero.hPVRL1/Vdog.PVRL4
cells as compared to Vero.dog.PVRL4 cell line. Syncytia formation
was also delayed in Vero.hPVRL1/VhPVRL4 cells following MeV
infection as compared to Vero.hPVRL4 cell line (data not shown).
Possibly, the PVRL1 scaffold may be less efﬁcient in presenting the
dog PVRL4 V domain to CDV H in Vero.hPVRL1/Vdog.PVRL4 cells
compared to native PVRL4 in Vero.dog.PVRL4 cells. This could lead
to a lower level of syncytia formation. Consistent with this
hypothesis, Muhlebach et al. showed that binding of soluble H or
MeV to V–Fc was less efﬁcient than binding to longer V–C2–C2–Fc,
using immunoblot analysis (Muhlebach et al., 2011).
The crystal structure of wild-type MeV H protein in complex
with the V domain of human PVRL4 described three binding
interfaces (Zhang et al., 2013). While site II and III contribute to
receptor–ligand interactions, site I confers strong stabilizing forces
via extensive hydrophobic interactions through four key residues
(F101, P102, A103 and G104) within the V domain (Zhang et al.,
2013). The FPAG motif within the V domain of human PVRL4
appears to be critical for binding to MeV H and is conserved in the
related dog PVRL4 V domain (Noyce et al., 2013; Zhang et al.,
2013). However, the signiﬁcance of these residues was never
conﬁrmed in actual virus cell infections. Our studies showed that
this motif plays an important role in CDV infections that are
mediated by dog PVRL4. Phenylalanine (F), proline (P), alanine
(A) and glycine (G) are non-polar amino acids leading to strong
hydrophobic interactions with MeV H (Zhang et al., 2013). Inter-
estingly, FPxG is a consensus amino acid sequence within the V
domain of all human nectins (Fig. 1A) (Harrison et al., 2012; Zhang
et al., 2013). The x amino acid is represented by threonine (T),
lysine (K) and leucine (L) in human PVRL1, PVRL2 and PVRL3
respectively (Fig. 1A) (Zhang et al., 2013). None of these receptors
are normally used by MeV (Muhlebach et al., 2011; Noyce et al.,
2011). Although the polar threonine and lysine residues might
decrease the strength of the non-polar hydrophobic interaction
between the FPxG motif and the hemagglutinin protein, the non-
polar leucine amino acid found in PVRL3 should have no effect on
this interaction. These data suggest that the three-dimensional
shape of either the V domain of PVRL3 or the receptor itself may
render the FPLG motif non-accessible to the viral hemagglutinin.
Taken together our results illustrate that MeV and CDV epithe-
lial cell infections are highly conserved among morbilliviruses.
The identiﬁcation of mutations in the V domain of PVRL4 that
are important for CDV entry activity sheds light on the molecular
interactions between CDV and PVRL4. This information could lead
to studies geared toward the production of antiviral agents that
interfere with the entry process.
Materials and methods
Cell culture and virus infections
Vero cells were purchased from the American Type Culture
Collection (Manassas, VA). Phoenix cells were obtained from
Dr. Craig McCormick (Dalhousie, University). The recombinant
wild-type CDV 5804PeH strain (von Messling et al., 2004) was
provided by Dr. Veronika von Messling. Wild type CDV was
propagated in Vero.dog.SLAM cells.
Molecular cloning of chimeric dog PVRL4 and human PVRL1 cDNAs
The chimeric dog.PVRL4/VhPVRL1 protein was constructed by
replacing the V domain of dog PVRL4 with the human PVRL1 V
domain. Brieﬂy, SacII restriction sites were added by mutagenesis at
each extremity of the V domain of dog PVRL4 and then subsequently
digested with SacII to remove the V domain (dog.PVRL4 V domain
(-)). The V domain from human PVRL1 (Origene) was ampliﬁed by
PCR using the primers encoding a SacII restriction site; (sense 50-
AAACCGCGGTCGGCAGGTGAACGACTCCATGT ATG-30 and antisense
50-AAACCGCGGAGCCGAGCGTGATTGAGTGGCTTTC-30). The amplicon
was subcloned into pcDNA3.1 (-) dog.PVRL4 V domain (-) via SacII
restriction sites within the vector. The SacII restriction sites were
subsequently removed by mutagenesis. A similar cloning strategy
was used to engineer the chimeric hPVRL1/Vdog.PVRL4 protein by
replacing the N-terminal 133 amino acid segment of human PVRL1
with the N-terminal 141 amino acid segment of dog PVRL4.
Site-directed mutagenesis
To generate dog PVRL4-blind CDV H protein, site-directed
mutagenesis (QuikChange II, Agilent Technologies) was performed
on the plasmid pCG-H5804PZeo to introduce the double muta-
tions P493S/Y539A. These mutations correspond to those reported
by Sawatsky et al. (2012). The dog.PVRL4/VFPAG-SSSY expression
plasmid containing the four mutations F132S/P133S/A134S/G135Y
was generated by site-directed mutagenesis.
Creation of stable cell lines by retrovirus transduction
To create stable cell lines expressing the chimeric dog PVRL4
and human PVRL1 proteins, dog.PVRL4/VhPVRL1, dog.PVRL4/VFPAG-
SSSY, and hPVRL1/Vdog.PVRL4 were subcloned into the pBMN-IRES-
Hygromycin retrovirus (a kind gift from C. McCormick). Phoenix
cells were subsequently transfected using Lipofectamine 2000
(Invitrogen) and supernatant containing the different chimeric
nectin-expressing viruses were collected at 3 days post transfec-
tion. Supernatants were brieﬂy clariﬁed at 1000g for 5 min and
subsequently incubated with Vero cells in the presence of 12 μg/
ml polybrene for 90 min at 1000g. Forty-eight hours post retro-
virus transduction, the cells were sub-cultured in the presence of
800 μg/ml hygromycin until no cells were present on the control
cell plate. These cells were tested for PVRL4 and PVRL1 expression
by ﬂow cytometry before being used for virus infections and
transfections.
Virus infections
Vero cells stably expressing empty vector (Vero), wild-type and
chimeric dog PVRL4 and human PVRL1 proteins were seeded into
12-well plates so they were conﬂuent approximately 24 h later.
Cells were infected with 5804PeH wtCDV at an MOI of 0.5 TCID50/
cell, for 1 h at 37 1C. Cell monolayers were washed twice with PBS
and replaced with DMEM containing 5% FCS. Cells were harvested
at day 3 after infection. TCID50 titers were determined by 50% end-
point titration on Vero.dog.SLAM cells, according to the Spear-
man–Kärber method. Data were expressed as means7the stan-
dard error of the mean.
Syncytia assays
Vero stable cell lines were seeded into 12-well plates so they
were 70% conﬂuent approximately 24 h later. Cells were then co-
transfected using Lipofectamine 2000 (Invitrogen) with plasmids
encoding CDV F together with CDV H or CDV HP493S/Y539A. At 24 h
and 72 h post transfection, phase contrast images were captured
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to visualize the extent of syncytia formation in Vero.dog.SLAM
cells and cell lines expressing the chimeric PVRL4 and PVRL1
molecules respectively. To visualize the syncytia more clearly, cells
were ﬁxed with methanol for 2 min, air dried, stained with Giemsa
(Sigma-Aldrich) diluted 1:20 with distilled deionized water virus
for 60 min, and washed with distilled deionized water. Cells were
viewed by light microscopy using a Leica DMI4000B inverted
microscope.
Microscopy
Infected and transfected cells were viewed by ﬂuorescence, phase
contrast, and light microscopy using a Leica DMI4000B inverted
microscope (Leica Microsystems) equipped with 5 , 10 , 20 , and
40 objectives. Images were processed using Leica Application Suite
software and Adobe Photoshop CS3 using only linear adjustments.
Flow cytometry
Cells were analyzed by ﬂow cytometry to determine the cell
surface expression of PVRL4 and PVRL1 on Vero stable cell lines.
Brieﬂy, cells were washed with PBS, non-enzymatically dissociated
and subsequently blocked in 2.5 μg of normal human IgG (R&D
Systems) for 10 min on ice followed by the addition of 10 μl of
either PE-conjugated monoclonal antibody against human PVRL4
27-351 (R&D Systems FAB2659P) or PE-conjugated mouse IgG2B
isotype control (R&D Systems IC0041P), and APC-conjugated
mouse monoclonal antibody against human PVRL1 31-334 (R&D
Systems FAB2880A) or APC-conjugated mouse IgG2A isotype
control (R&D Systems IC003A) antibodies for 45 min on ice. Cells
were washed twice in PBS containing 1% BSA, 5 mM EDTA, and
0.1% sodium azide and then ﬁxed in 1% paraformaldehyde.
Samples were run on an ADP Cyan Flow Cytometer (Beckman
Coulter) and data were processed using FlowJo cytometry analysis
software (Tree Star, Inc).
Data analysis
Data were expressed as means7the standard error of the mean
unless otherwise indicated. Analysis of variance (ANOVA) was
performed to identify statistically signiﬁcant differences in CDV
5804PeH titrations. P values below 0.05 were considered statistically
signiﬁcant. Overlays of phase and ﬂuorescence micrographs were
processed using only linear adjustments in Photoshop CS3.
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